Drug intelligence / Profile preview

methyl-d9-choline

Development stage
Unknown
Modality
Classical Binding Small Molecules → Small Molecules
Administration
Intravenous
01

Overview

Methyl-d9-choline is an isotopically labeled analogue of choline in which all nine hydrogen atoms of the three methyl groups are replaced by deuterium. It is primarily used as a tracer in metabolic studies and clinical research to investigate choline metabolism and related pathways. Methyl-d9-choline has been investigated in early-phase clinical trials for its use as a tracer to study endoplasmic reticulum stress in non-alcoholic fatty liver disease (NAFLD). As a small molecule analog of endogenous choline, it participates in similar biochemical pathways but can be distinguished analytically due to its deuterium labeling[1][7][10].

Other names
2-(Tri(2H3)methylaminio)ethanol(2-hydroxyethyl)tri(2H3)methylazanium2-hydroxy-N,N,N-trimethyl-d9-ethanaminium2-hydroxy-N,N,N-tris(methyl-d3)ethan-1-aminium50673-41-1
02

Targets

PCYT1A (Phosphate cytidylyltransferase 1, choline-alpha)PEMT (Phosphatidylethanolamine N-methyltransferase)CHKA (Choline kinase)

Beyond the preview

Go deeper on methyl-d9-choline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methyl-d9-choline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call